Structural Formula (Eto06 0000 01)
Etomidate Injection, Solution
Product Images NDC 65219-445
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Etomidate (NDC 65219-445). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fresenius Kabi Logo (Eto06 0000 02)
Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Vial Label)
This text describes the medication Etomidate in a 10 mL single-dose vial for intravenous use only. It includes information on the contents of the medication, storage instructions, manufacturer details, and a code for identification. The usual dosage information is advised to be obtained from the package insert, and any unused portion should be discarded.*
Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Carton)
This is a product label for Etomidate Injection, USP, intended for intravenous use only. Each mL contains 2 mg of Etomidate USP, 35% v/v propylene glycol USP, and water for injection USP. The product comes in 10 x 10 mL single-dose vials. It is recommended to store this sterile, nonpyrogenic medication at 20° to 25°C (68° to 77°F). The label includes details for batch overprinting with 2D code, Sr. No, GTIN, Lot number, and Expiry date during online packing.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
